Certara Corporation Expands Senior Scientific Team

Published: Sep 06, 2012

ST. LOUIS--(BUSINESS WIRE)--Certara™, a leading provider of scientific software and consulting services to improve productivity and decision-making from drug discovery through drug development, today announced that Christine E. Garnett, PharmD will join the organization as Principal Scientist. In this role, Dr. Garnett will lead development of next-generation cardiac safety modeling tools on the Phoenix™ software platform and will also work closely with Pharsight’s global consulting services team on predictive modeling engagements that leverage early clinical study data to assess the cardiac proarrhythmic risk of new drug candidates.

Back to news